SciTech Development Advances to Next Stage of Clinical Trial for ST-001 nanoFenretinide
SciTech Development Advances to Next Stage of Clinical Trial for ST-001 nanoFenretinide NEWS PROVIDED BY SciTech Development 13 Jan, 2025, 09:00 ET **Encouraging Data from Accelerated Trial Supports Progress for T-cell Non-Hodgkin Lymphoma.** DETROIT, Jan. 13, 2025 /PRNewswire/ — SciTech Development, a clinical-stage pharmaceutical company specializing in oncology, is pleased to announce the initiation…